Invitation to Submit to act a Participating Centre within the SABR CtE Programme


NHS ARDEN AND GREATER EAST MIDLANDS COMMISSIONING SUPPORT UNIT

Reference
SpecComm/SabreCtE/WSimms
Date Published
06/05/2015
Value
£1
Closing Date
19/05/2015
Contract Start Date
15/06/2015
Contract End Date
14/06/2018
Contract Type & Status
Contract : Closed
Suitable for SME?
No
Region
Any region

Description

Invitation to Submit to act a Participating Centre within the SABR CtE Programme Arden and Greater East Midlands Commissioning Support Unit (Arden &GEM CSU) on behalf NHS England are inviting providers to apply to take part in a new Commissioning through Evaluation (CtE) programme for Stereotactic Ablative Radiotherapy (SABR). The CtE programme enables patients to access promising new treatments which are not routinely commissioned, whilst new data is collected within a formal evaluation programme, potentially leading to the development of a clinical commissioning policy for future use. Applications are invited from providers wishing to act as participating centres in a new CtE programme focussing on SABR in the treatment of oligometastatic disease, primary hepatocellular carcinoma (HCC) and re-irradiation of the spine and pelvis. It is expected that a smaller number of providers will act as participating centres for HCC and re-irradiation as compared to those for Oligometastatic disease. Providers wishing to participate in the programme must clearly state the scope of their application within the template. CtE is an innovative programme introduced by NHS England to support promising new treatments where the evidence base is not yet sufficiently developed to support routine commissioning. CtE enables new data to be collected within a formal evaluation programme and is run in partnership with the National Institute for Health Care Excellence (NICE). SABR is currently only routinely commissioned as a treatment for non-small cell lung cancer. The SABR CtE programme will run for a period of up to three years and it expected that the first patients will begin to receive treatment from the CtE from 15 June 2015. This service will be live on 6th May on the Arden & GEM CSU e-tendering portal (Bravo). All submissions will be evaluated using the scoring criterion which is contained within the ITT attachments section ‘Document 1 - ItS Instructions’. Clarifications may be asked during the process, the deadline for ITT clarification questions is 5pm on 15th May 2015. All correspondence relating to this process throughout all stages of the process must be managed through the Arden & GEM CSU eTendering AGEM Portal Bravo only. Providers wishing to submit an ITT to deliver this service can do so by logging onto Arden GEM CSUs procurement portal (Bravo) by no later than 5pm on 20th May at: https://gemcsu.bravosolution.co.uk/web/login.html To Register on the portal: »From the portal Home Page, click the ‘Click Here to Register’ link »Accept the terms & conditions for using the portal »Complete your organisation & personal details »Choose a memorable username and submit »You will shortly be sent an email with your unique password, please treat this securely (if you lose it there is a ‘Forgot my Password’ link on the portal homepage)


Industry Sector


Contact Details - Login to view

CONTACT INFORMATION FOR THE CONTRACTOR
NAME, TELEPHONE NUMBER, EMAIL ADDRESS,
POSTAL ADDRESS AND WEB ADDRESS


More Information

Contact Details - Login to view

information fed from tender feed information fed from tender feed information fed from tender feed